KRT19 is a known prognostic biomarker for multiple cancer types, including PCs, and increased KRT19 was closely correlated with a poor prognosis of patients with PC (Saha et al. 2017; Tang et al. 2014; Yao et al. 2016). This evidence concerns the gene KRT19 and cancer.